PCN95 POLICY-MAKING FOR EXPENSIVE INNOVATIVE DRUGS IN FRANCE- ECONOMIC IMPACT AND INFLUENCE ON STAKEHOLDERS! BEHAVIOURS OF POTENTIAL DECISIONS ABOUT TAXANES
Abstract
Authors
HM Spath B Favier MO Carr re
HM Spath B Favier MO Carr re
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now